… nucleic acid vaccines. By mid-2021 three billion doses of COVID-19 vaccine have been
administered around the world, mostly in high-income countries. COVID-19 vaccination provides …

… people receiving candidate COVID-19 vaccines to understand … for prioritizing among the
COVID-19 vaccine candidates with … enhanced severity of COVID-19 disease, after vaccination. …

… have raised more challenges, both for the vaccine developers as well as the … vaccines with
examples of COVID-19 vaccines, their rapid development compared to the traditional vaccine…

… race to develop a COVID-19 vaccine or the distribution of a candidate vaccine to clusters of
… be dangerous and erode trust in both the vaccine and regulatory bodies. In this weird contest…

… -positive cases with one dose of messenger RNA vaccine. … Data on the effectiveness of
Covid-19 vaccines against clinical … of two Covid-19 vaccines, BNT162b2 and ChAdOx1 nCoV-19 (…

… There is probably little or no difference between most vaccines and placebo for serious …
of COVID‐19 vaccines, and this review is updated regularly on the COVID‐NMA platform (covid-…

… the rapid pace of vaccine approval, the COVID-19 vaccine trials generated substantially
more short-term safety data than would be available during a typical vaccine approval process. …

… less effective and the need for novel drugs and vaccines is more evident than ever. This
author … article [19]. In this new article, the current status of nine COVID-19 vaccines that were in …

… the outbreak of novel coronavirus erupted and then world-… COVID-19 vaccine before
September, 2020 as per very optimistic estimates. This is because a successful COVID-19 vaccine …

… than 100 COVID-19 vaccine candidates were in … COVID-19 vaccines is encouraging.
However, we and others have raised concerns about the safety of some of the COVID-19 vaccine …